e-learning
resources
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The inflammasome pathway in stable COPD and acute exacerbations
Rosa Faner, Patricia Sobradillo, Aina Noguera, Cristina Gomez, Tamara Cruz, Alejandra López-Giraldo, Eugeni Ballester, Nestor Soler, Juan I. Arostegui, Pablo Pelegrín, Roberto Rodriguez-Roisin, Jordi Yagüe, Borja G. Cosio, Manel Juan, Alvar Agustí
Source:
ERJ Open Res 2016: 00002-2016
Journal Issue:
July
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Rosa Faner, Patricia Sobradillo, Aina Noguera, Cristina Gomez, Tamara Cruz, Alejandra López-Giraldo, Eugeni Ballester, Nestor Soler, Juan I. Arostegui, Pablo Pelegrín, Roberto Rodriguez-Roisin, Jordi Yagüe, Borja G. Cosio, Manel Juan, Alvar Agustí. The inflammasome pathway in stable COPD and acute exacerbations. ERJ Open Res 2016: 00002-2016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Activation of the inflammasome pathway during exacerbations of COPD
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011
Clinical pathway for acute COPD exacerbations
Source: Eur Respir J 2004; 24: Suppl. 48, 64s
Year: 2004
Altered inflammasome activity in bacterial acute exacerbations of COPD (AECOPD)
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Inflammasome activity in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012
COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Neutrophil extracellular traps (NETs) in COPD: A potential novel mechanism for host damage in acute exacerbations
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Recruitment of blood fibrocytes during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4 dependent pathway
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015
MUC1-CT mediates corticosteroid responses in COPD
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016
The role of complement activation in COPD exacerbation recovery
Source: ERJ Open Res, 2 (4) 00027-2016; 10.1183/23120541.00027-2016
Year: 2016
Comparative study of hospitalized patients with acute exacerbation of COPD with and without carbon dioxide retention
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Increased interferon and decreased NRF2-PPARG signaling is associated with frequent exacerbations in COPD
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016
Vascular-platelet hemostasis parameters in the stable phase and in acute exacerbation (AE) of COPD
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Acute COPD exacerbations cause alteration of the endothelium-coagulative system
Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD
Year: 2003
Chronic sputum production and airway inflammation in COPD in the stable state and at exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 442s
Year: 2005
Viruses as a critical trigger in the development of acute exacerbations of asthma
Source: International Congress 2019 – Mechanisms underlying acute exacerbation of respiratory disease
Year: 2019
Eosinophilia as marker of outcome in hospitalised patients with AECOPD
Source: Annual Congress 2013 –COPD and infections
Year: 2013
Viruses as a critical trigger in the development of acute exacerbations of asthma
Source: ERS Lung Science Conference 2019
Year: 2019
The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept